Extended dosing intervals of ixekizumab for psoriasis: A single-center, uncontrolled, prospective study - 05/06/21
Doi : 10.1016/j.jaad.2021.04.093
Li-Ran Ye, MSc, Bing-Xi Yan, MD, Xue-Yan Chen, MD, Si-Qi Chen, MSc, Jia-Qi Chen, MD, PhD ⁎ 
, Xiao-Yong Man, MD, PhD ⁎
and
, Xiao-Yong Man, MD, PhD ⁎ and
Chinese Psoriasis Real World Evidence Research Group (CPRWERG)
Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
∗Reprint requests: Jia-Qi Chen, MD, PhD, Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, ChinaDepartment of DermatologySecond Affiliated HospitalZhejiang University School of Medicine88 Jiefang RoadHangzhouChina∗Reprint requests: Xiao-Yong Man, MD, PhD, Department of Dermatology, Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, ChinaDepartment of DermatologySecond Affiliated HospitalZhejiang University School of Medicine88 Jiefang RoadHangzhouChina
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Saturday 05 June 2021
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
| Author Ye and Dr Yan contributed equally to this article. |
|
| Funding sources: This work was supported by grants from the National Natural Science Foundation of China (NSFC) (NO. 81930089, 81630082). |
|
| IRB approval status: The study was approved by the Human Research Ethics Board of Second Affiliated Hospital, Zhejiang University School of Medicine (approval number 2020-485) and was conducted according to the principles of the Declaration of Helsinki. Informed consent was obtained from all the participants in the study. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?